期刊文献+

头孢菌素类药物罕见不良反应DRESS综合征文献分析

Literature analysis of rare adverse reactions of DRESS syndrome caused by cephalosporins
原文传递
导出
摘要 目的:总结头孢菌素类药物致伴嗜酸性粒细胞增多和系统症状的药疹综合征(drug reaction with eosinophilia and systemic symptoms syndrome,DRESS综合征)的发生情况及特点,为临床安全合理用药提供参考。方法:检索国内外相关数据库,收集头孢菌素类药物导致DRESS综合征的病例报道,对筛选出的病例进行统计和分析。结果:共收集到有效文献34篇,涉及患者36例,男性22例(61.11%),女性14例(38.89%);致敏药物为第三代头孢菌素的病例数共24例(66.67%);头孢菌素类药物致DRESS综合征的潜伏期均值为(19.40±11.25)d;24例(66.67%)患者在用药14 d之后出现不良反应;临床症状主要表现为发热、皮疹、面部水肿、淋巴结肿大、嗜酸性粒细胞增高及内脏受累,最常见受累的器官为肝脏24例(66.67%),其次是肾脏11例(30.56%)。所有患者在予以皮质类固醇、抗病毒药物、抗组胺药物、皮质类固醇联合乙酰半胱氨酸、免疫球蛋白、免疫抑制剂和贝那利珠单抗等治疗后,33例(91.67%)好转,1例(2.78%)患者结局未知,2例(5.56%)患者死亡,其中1例死于多器官功能衰竭,1例死于急性心肌心包炎。结论:头孢菌素类药物致DRESS综合征的患者各年龄段均有发生,多数患者潜伏期大于14 d;致敏药物主要以第三代头孢菌素为主;早期诊断和停用致敏药物对改善患者的预后至关重要。皮质类固醇、抗病毒药物、免疫球蛋白、免疫抑制剂、贝那利珠单抗等治疗药物有益DRESS综合征患者的预后。临床上应提高对头孢菌素类药物可能导致DRESS综合征的认识和处置水平,以减少不良反应的发生。 OBJECTIVE To summarize the occurrences and characteristics of drug reaction with eosinophilia and systemic symptoms syndrome(DRESS syndrome)caused by cephalosporin to provide references for clinical safe and rational drug dosing.METHODS The relevant domestic and international databases were searched for case reports of DRESS syndrome caused by cephalosporin.The retrieved cases fulfilled the standards for statistics and analysis.RESULTS A total of 34 eligible items were collected.There were 22 males(61.11%)and 14 females(38.89%).A total of 24 cases(66.67%)received third-generation cephalosporins as sensitizers.The average latency of DRESS syndrome caused by cephalosporins was(19.40±11.25)day.And 24 patients(66.67%)experienced adverse reactions after 14-day medication.The major clinical symptoms included fever,rash,facial edema,lymphadenopathy,elevated eosinophils and visceral involvement.The most common affected organs were liver(n=24,66.67%)and kidney(n=11,35.48%).After receiving corticosteroids,antiviral drugs,antihistamines,corticosteroids plus acetylcysteine,immunoglobulins,immunosuppressants and benazezumab,the outcomes were improvement(n=33,91.67%),unknown(n=1,3.23%)and death(n=2,5.56%).The mortality causes were multiple organ failure(n=1)and acute myocardial pericarditis(n=1).CONCLUSION DRESS syndrome caused by cephalosporin may occur in all age groups with an incubation period of over 14 days.The major allergens are third-generation cephalosporins.Early diagnosis and timely discontinuation are crucial for improving patient outcomes.Corticosteroids,antiviral drugs,immunoglobulins,immunosuppressants and benazezumab are beneficial.In clinical practices,it is necessary to improve the understanding and management level of cephalosporins causing DRESS syndrome to lower the occurrence of adverse reactions.
作者 王樟根 竺嘉幸 周峰 周晓峰 郭妍 刘琼 WANG Zhanggen;ZHU Jiaxing;ZHOU Feng;ZHOU Xiaofeng;GUO Yan;LIU Qiong(Department of Pharmacy,Hainan Hospital,Chinese PLA General Hospital,Hainan Sanya 572000,China;Department of Pharmacy,Sanya Rehabilitation Center of Chinese PLA Joint Logistics Support Force,Hainan Sanya 572000,China;Department of Medical Security Center,Hainan Hospital,Chinese PLA General Hospital,Hainan Sanya 572000,China)
出处 《中国医院药学杂志》 CAS 北大核心 2024年第14期1663-1668,共6页 Chinese Journal of Hospital Pharmacy
基金 海南省重大科技计划资助(编号:ZDKJ2019012)。
关键词 头孢菌素类药物 DRESS综合征 文献分析 cephalosporins DRESS syndrome literature analysis
  • 相关文献

参考文献7

二级参考文献36

  • 1汪辉,陈景勇,张石楠,吕良,叶雯,余江河.头孢他啶/他唑巴坦复方对产β-内酰胺酶耐药菌株的增效作用研究[J].药物生物技术,2004,11(6):364-367. 被引量:3
  • 2周东升,潘晓龙,熊自忠,吴祥林,吴志平,富铮,蒋静.产超广谱β内酰胺酶大肠埃希菌的耐药性及基因型研究[J].中国感染与化疗杂志,2006,6(5):317-320. 被引量:11
  • 3史强.280例儿童抗感染药物不良反应报告分析[J].儿科药学杂志,2007,13(4):28-29. 被引量:10
  • 4Paterson D L. "Collateral damage" from cephalosporin or quinolone antibiotic therapy [J]. Clin Infect Dis, 2004, 38 (Suppl 4) :S341-S345.
  • 5Du B, Chen D, Liu D, et al. Restriction of third-generation cephalosporin use decreases infection-related mortality [J]. Crit Care Med, 2003,31 (4) :1088-1093.
  • 6国家食品药品监督管理局.2011年国家药品不良反应监测年度报告[EB/OL].(2012-05-31)[2012-07-20].http://www.sda.gov.cn/WS01/C1.0078/72193.html.
  • 7Winokur P L, Vonstein D L, Hoffman L J ,et al. Evidence for trans/er of CMY-2 AmpC beta lactamase piasmids between Escherichla coli and SaLmonella isolates from food animals and humans[J]. Antimicrob Agents Chemother, 2001,45 (10) :2716-2722.
  • 8Coque T M,Oliver A,P:rez Diaz J C,et al. Genes encoding TEM-4,SHV-2 and CTX-M-10 extended spectrum beta-lac- tamases are carried by multiple Klebsiella pneumoniae clones in a single hospital ( Madrid, 1989 to 2000 ) [J]. Antimicrob Agents Chemother, 2002,46 (2) : 500-510.
  • 9Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement, MIOO-S20[EB/OL]. ( 2010-01-01 ) [2012-07-20]. http://www, techstreet, eom/cgi-bin/detail? doe_no: clsi:7CmlO0 s20 : product id: 1662846.
  • 10Dubreuil L J, Mahieux S, Neut C, et al. Anti-anaerobic activity of a new 13-1actamase inhibitor NXL104 in combination with f:-lactams and metronidazole[J]. Int J Antimicrob Agents, 2012,39(6) :500-504.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部